ESPICOM Pharmaceutical and Medical Company Profiles [510]

HOME : Support : Dialog Search Aids : Bluesheets
View Bluesheets by \| Database Name \| File Number \| Subject \| OneSearch Categories \| Search Options \|

	510
ESPICOM Pharmaceutical and Medical Company Profiles

Last Loaded on Web: Wednesday, May 01, 2013

Last Update To Bluesheet: October 13, 2011

Bluesheet Contents PDF version

File Description	Dialog File Data	DIALINDEX/OneSearch Categories	Basic Index	Rank
Subject Coverage	Document Types Indexed	Contact	Additional Indexes	Predefined Format Options
Tips	Geographic Coverage	Terms and Conditions	Limit	Rates
Print Counterparts	Special Features	Sample Record	Sort

File Description [top]

ESPICOM Company Profiles are based on four publication areas: Medical Device Companies Analysis, 4D Pharma, Generic Company Analysis and Cancer Drug Companies. Reports from this database provide detailed analyses of the world's leading pharmaceutical, generic, medical device and cancer drug companies.

Typical applications for File 510 include: company performance, structure and strategy, tracking product introductions, following new technologies, obtaining annual sales figures by region, monitoring product introductions, watching R&D and development cycles, and monitoring approvals and clearances.

Tips [top]

USE FILE 510

to track medical device and pharmaceutical companies.

USE SF=TABLE

to locate records that contain tables or exhibits.

USE REPORT TITLES

to gather all records together for an individual report.

SELECT ABBOTT?/MT REPORT S1/TITLES

Subject Coverage [top]

File 510 includes profiles of Medical Device, Pharmaceutical, Generic and Cancer Drug Companies. Typical profiles include:

Medical Device Company analysis

Financial Review
Strategic Focus
Products
Research and Development
Agreements
Mergers and Acquisitions
Investments, Divestitures and Litigations
Key Corporate Events

Pharmaceutical, Generic and Cancer Drug Companies Analysis

Financial Position
Company Strategy
Product and Pipeline
Therapeutic Area
Research and Development

Print Counterparts [top]

Medical Device Companies Analysis

Dialog File Data [top]

Dates Covered:	1995 to Current
File Size:	36,732 records as of October 2011
Update Frequency:	Irregular

Document Types Indexed [top]

Market research reports

Geographic Coverage [top]

International

Special Features [top]

ERA Available
Graduate Education Program
KWIC and HILIGHT Available

DialIndex/OneSearch Categories [top]

ACRONYM	CATEGORY NAME
CODIR	Company Directories
DRUGPRO	Pharmaceutical Company Profiles
MERGEACQ	Mergers and Acquisitions

Contact [top]

ESPICOM Pharmaceutical and Medical Company Profiles is provided by ESPICOM Business Intelligence. Questions concerning file content should be directed to:

ESPICOM Business Intelligence
Mark Hamson
City Fields Business Park, City Fields Way, Tangmere
Chichester, West Sussex PO20 8FS
U.K.

Telephone:	+44 1243 53 3322
Fax:	+44 1243 53 3418
E-Mail:	mark_hamson@espicom.com

Terms and Conditions [top]

Database is copyrighted by ESPICOM Business Intelligence. For Dialog's Redistribution and Archive policy, enter HELP ERA online. Dialog Standard Terms & Conditions apply.

Dialog Standard Terms & Conditions apply.

SAMPLE RECORD [top]

	`DIALOG(R)File 510:ESPICOM Pharm & Med Co. Profile`
	`(c) 2003 ESPICOM Bus. Int. All rts. reserv.`

	`00012596`

/TI,SE=	`Financial Commentary: Financial Commentary - Profit & Loss--Balance Sheet`

/MT, MT=	`Main Title: ALTANA INC 2000 Medical Device Company`
PD=, PY=	`Pub. Date: APRIL 2000`
CS=	`Source: Pharmaceutical Companies Analysis`
	`Telephone: +44 (0) 1243 533322`
WD=	`Word Count: 413 (1 pp.)`
LA=	`Language: English`

/TX	`Financial Commentary`

	`Profit & Loss`
	`Despite the difficult economic conditions in a number of important`
	`markets, Altana strengthened its position during 1998, fuelled by the`
	`strong international orientation of the company, successful new products`
	`and further acquisitions.`

	`Net sales improved by 9.8 per cent to DM 2,887 million, with 3.0 per cent`
	`relating to acquisitions within the Chemicals division. Sales in Germany`
	`grew by 6.2 per cent to DM 877 million and international sales went up by`
	`11.4 per cent to DM 2,010 million, or a record 69.9 per cent of total`
	`sales, with acquisitions contributing 4 per cent to the growth.`

	`Within the Pharmaceuticals division, the 8.4 per cent rise in sales to DM`
	`1,907 million was primarily due to new products in the therapeutic range.`
	`Supported by further growth in the market for pantoprazole, sales of DM`
	`571 million were achieved. Divisional profits totalled DM 213 million and`
	`showed a disproportionate increase of 18.3 per cent, due to the company's`
	`determined business policy.`

	`Balance Sheet`
	`Altana's total assets amounted to DM 2,898 million, an increase of 7.3 per`
	`cent from 1997. The 10.6 per cent increase in non-current assets to DM 801`
	`million was primarily the result of Altana's new acquisitions for the`
	`Chemicals division, in addition to the comparatively high level of`
	`investment during the year. The 5.7 per cent increase in inventories and`
	`trade accounts receivable to DM 810 million, or 27.7 per cent of total`
	`assets, was principally in the course of business expansion. Liquid assets`
	`were 38.1 per cent of total assets at DM 1,103 million, of which cash`
	`constituted DM 311 million (+DM 38 million).`

	`Shareholders' equity totalled DM 1,569 million, or 54.1 per cent of the`
	`balance sheet total, up 8.0 per cent from 1997. Return on equity capital`
	`went up by 0.8 percentage points to 12.9 per cent. Reserves, consisting of`
	`provisions and accruals accounted for 27.3 per cent of the balance sheet`
	`total. Therefore, again in 1998, over 80 per cent of all liabilities was`
	`accounted for by shareholders' equity and reserves. Within liabilities,`
	`which amounted to DM 505 million, DM 244 were borrowings, DM 159 million`
	`were trade payables, and DM 102 million were taxation and social`
	`security.`

	`THIS IS THE FULL-TEXT.`
	`COPYRIGHT 2000 ESPICOM Business Intelligence Ltd`

	`Country: GERMANY`
	`Industry: HEALTH CARE`
	`Company Names (DIALOG Generated): Altana ; Profit & Loss`

SAMPLE REPORT TITLES SEARCH [top]

	`?s genetic(w)engineer?`
	`182 GENETIC`
	`399 ENGINEER?`
	`S1 24 GENETIC(W)ENGINEER?`
	`?report s1/titles`
	`S2 24 Sort 1/ALL/PD,D MT,A FROM 510`
	`DIALOG(R) ONLINE TABLE OF CONTENTS`
	`LIST OF REPORT TITLES`

	`ITEM NUMBER, MAIN TITLE`
	`------------------------------------------------------`
	`1 ALTANA INC 2000 Medical Device Company`
	`F510: Pharmaceutical Companies Analysis`
	`April 2000/35 records`

	`2 OTSUKA 2000 Medical Device Company`
	`F510: Pharmaceutical Companies Analysis`
	`April 2000/31 records`

	`3 Sumitomo Chemical Company Limited 2000 Medical Device Company`
	`F510: Pharmaceutical Companies Analysis`
	`March 2000/31 records`

	`4 BASF 2000 Medical Device Company`
	`F510: Pharmaceutical Companies Analysis`
	`February 2000/62 records`

	`Enter one item number, P for next page, or EXIT to leave TITLES:`
	`?1`
	`Enter (S)ection Headings only, (C)omplete table of contents,`
	`M to return to Main Menu Listing or EXIT to leave TITLES:`
	`?c`

	`DIALOG(R) F510: Pharmaceutical Companies Analysis`
	`Table of Contents`

	`Main Title: ALTANA INC 2000 Medical Device Company`
	`Date: April 2000`
	`----------------------------------------------------------------------`
	`Profile Overview`
	`1 Profile Overview - Table 1, Address--Table 2, Principal Operating`
	`Results--Table 3, Main Areas; SF=TABLE; AN=00012594`

	`Table 4, Financial Indicators`
	`2 Table 4, Financial Indicators; SF=TABLE; AN=00012595`

	`Financial Commentary`
	`3 Financial Commentary - Profit & Loss--Balance Sheet; AN=00012596`
	`4 Cash Flows--Outlook--Notes; AN=00012597`

	`Recent History/Corporate Strategy Part 1`
	`5 Recent History/Corporate Strategy Part 1; AN=00012598`

	`Recent History/Corporate Strategy Part 2`
	`6 Recent History/Corporate Strategy Part 2; AN=00012599`
	`7 Acquisitions--Divestitures; AN=00012600`
	`(. . . )`

BASIC INDEX [top]

SEARCH SUFFIX	DISPLAY CODE	FIELD NAME	INDEXING	SELECT EXAMPLES
None	None	All Basic Index Fields	Word	S ADULT(W)NUTRITION
/CN	CN	Country Name	Word	S GERMANY/CN
/DE	DE	Industry Description	Word	S HEALTH(W)CARE/DE
/TX	TX	Text	Word	S NEW(W)PRODUCT?/TX

ADDITIONAL INDEXES [top]

SEARCH PREFIX	DISPLAY CODE	FIELD NAME	INDEXING	SELECT EXAMPLES
CN=	CN	Country Name	Phrase	S CN=UNITED STATES
CS=	CS	Corporate Source	Phrase	S CS=PHARMACEUTICAL COMPANIES?
IN=	IN	Industry Description	Phrase	S IN=HEALTH CARE
LA=	LA	Language	Phrase	S LA=ENGLISH
PY=	PY	Publication Year	Phrase	S PY=2000
SF=	SF	Special Feature	Phrase	S SF=TABLE
UD=	None	Update	Phrase	S UD=9999
WD=	WD	Word Count	Numeric	S WD=400:500

LIMIT [top]

SUFFIX	FIELD NAME	EXAMPLES
/NONUS	Report has non-U.S. emphasis	S ROCHE/NONUS
/US	Report has U.S. emphasis	S S1/US
/YYYY	Publication Year	S S1/2007

SORT [top]

SORTABLE FIELDS	EXAMPLES
CN, CS, IN, PY, WD	SORT S6/ALL/WD

RANK [top]

RANK FIELDS	EXAMPLES
All phrase- and numeric-indexed fields in the Additional Indexes can be ranked.	RANK IN S3

USER-DEFINED FORMAT OPTIONS [top]


User-defined formats can be specified using the display codes indicated in the Search Options tables.	TYPE S3/MT,TI/1-3

PREDEFINED FORMAT OPTIONS [top]

NO.	DIALOGWEB FORMAT	RECORD CONTENT
1	--	DIALOG Accession Number
2	--	Full Record except Text
3	Medium	Full Record except Text
5	Long	Full Record
6	Free	Main Title, Title, Publication Date, Section Name, Word Count
8	--	Main Title, Title, Publication Date, Section Name, Country Name, Industry Name, and Word Count
9	Full	Full Record
K	--	KWIC (Key Word In Context) displays a window of text; may be used alone or with other formats

DIRECT RECORD ACCESS [top]

FIELD NAME	EXAMPLES
DIALOG Accession Number	TYPE 00021290/9 PRINT 00016717/2

Rates [top]

Rates For File: ESPICOM Pharmaceutical and Medical Company Profiles[510]
Cost per DialUnit:                $17.60
Cost per minute:                   $2.52
Report Elements                    $1.00
TITLES Report(s)                   $0.00
Rank Elements                      $0.00

Format    Types   Prints
     1    $0.00    $0.00
     2    $7.00    $7.00
     3    $7.00    $7.00
     5   $12.00   $12.00
     6    $0.00    $0.00
     8    $0.35    $0.35
     9   $12.00   $12.00
KWIC95    $1.50       NA
KWIC96    $1.50       NA

REDIST/COPY Multiplier Table:

      Range      Multiplier
        1-2       1.00
       3-25       1.50
     26-100       3.00
    101-200       4.00
    201-500       6.00
   501-1000       8.00
 1001 or more    10.00

ARCHIVE Multiplier Table:

      Range      Multiplier
       1-25       1.50
     26-200       3.00
    201-500       6.00
   501-1000       8.00
 1001 or more    10.00

[top]